Related Experiment Video
Updated: Jun 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
Niraj K Shenoy1, Sangolli M Prabhakar
1#301-B, Ranka Colony, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India.
Abstract:
Finasteride is an important drug for the management of androgenetic alopecia. However, there are concerns about the possible side effects of the drug such as impotence. Recently stray reports have appeared about the occurrence of male breast carcinoma in patients who received the drug. These have been looked in to by Medicines and Health care products Regulatory Agency (MHRA). This article summarizes the MHRA report.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Prevention
Some...

